Bob Ward, President and CEO of DSM PTG, talks about a joint development project his company is working on to develop an affinity therapy device that has applications with infectious and inflammatory diseases. Visit http://www.dsm.com to find out more about DSM PTG.
Link to this comment:
All Comments (0)